Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs Business Wire Silence Therapeutics plc, (Nasdaq: SLN), (“Silence” or the “Company”), a global clinical-stage biotechnology company developing novel short interfering RNA (“siRNA”) therapies, today announced the closing of its previously announced underwritten public offering of 14,907,407 American Depositary Shares (“ADSs”), each representing three ordinary shares of £0.05 each in the capital of the Company, in the United [...]
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares Business Wire Silence Therapeutics plc (“Silence” or the “Company”), a global clinical-stage biotechnology company developing novel short interfering RNA (“siRNA”) therapies, today announced that it has commenced an underwritten public offering of approximately $150 million of its American Depositary Shares (“ADSs”), each representing three ordinary shares of £0.05 each in the capital of the Company, in the [...]
AngloGold Ashanti Q2 30 June 2026 Earnings Release and Dividend Declaration Business Wire Q2 2026 EBITDA*(5) +46% to $2.0bn • Q2 2026 free cash flow* +36% to $727m • YTD free cash flow* $1.9bn • Q2 2026 interim dividend of $364m, or 72 cps • Proposed $2.0bn share repurchase programme approved • Net cash*(5) of $991m after debt buyback
Fluidra Delivers a Strong First Half of 2026 and Maintains Positive Momentum in a Dynamic Environment July 30, 2026 Sales increased by 5% at constant FX to €1,258 million, driven by Fluidra’s customer focus and consistent execution Adjusted EBITDA grew by 6% at constant FX to €321 million, supported by firm cost discipline The company signed an agreement to acquire Hydrapro, a French manufacturer specializing in water treatment, to further support its growth Fluidra launches a €40 million share buy-back program and maintains full-year guidance
AngloGold Ashanti Publishes Notice of General Meeting in Relation to Proposed Share Repurchase Programme July 1, 2026 Shareholders of AngloGold Ashanti plc (“AngloGold Ashanti”, “AGA” or the “Company”) (NYSE: AU; JSE: ANG) are advised that the Company has today, Wednesday 1 July 2026, published its notice of meeting (the “Notice”) for a general meeting of its shareholders in relation to the proposed share repurchase programme (the “General Meeting”). The General Meeting is [...]
CRH Continues Share Buyback Program April 30, 2026 CRH (NYSE: CRH), the leading provider of building materials, is pleased to announce that it has completed the latest phase of its share buyback program, returning a further $0.3 billion of cash to shareholders. This brings total cash returned to shareholders under our ongoing share buyback program to $10 billion since its commencement in May [...]
REPLY S.p.A.: Shareholders’ Meeting Approves the 2025 Financial Statements April 23, 2026 Consolidated turnover of €2,483.6 million (€2,300.5 million in 2024); Group net profits of €250.9 million (€211.1 million in 2024). Approval of the proposal to distribute a dividend of €1.35 per share. Approval of the plan for the purchase and/or disposal of treasury shares.
AngloGold Ashanti Holdings plc Announces Pricing of Capped Cash Tender Offers for Part of Its 3.375% Notes Due 2028, 3.750% Notes Due 2030 and 6.500% Notes Due 2040 April 14, 2026 AngloGold Ashanti Holdings plc (the “Offeror”), a company incorporated under the laws of the Isle of Man, announces today the pricing of the previously announced capped cash tender offers that the Offeror commenced on March 30, 2026 (the “Offers”), for up to $650,000,000 aggregate purchase price (exclusive of Accrued Interest), for part of its outstanding [...]
AngloGold Ashanti Holdings plc Announces Early Results of Capped Cash Tender Offers for Part of Its 3.375% Notes Due 2028, 3.750% Notes Due 2030 and 6.500% Notes Due 2040 April 14, 2026 AngloGold Ashanti Holdings plc (the “Offeror”), a company incorporated under the laws of the Isle of Man, announces today the early results of the previously announced capped cash tender offers that the Offeror commenced on March 30, 2026 (the “Offers”), for up to $650,000,000 aggregate purchase price (exclusive of Accrued Interest), for part of its [...]
Argan, Inc. Announces Increase to Share Repurchase Program, Declares Regular Quarterly Cash Dividend of $0.50 Per Common Share April 8, 2026 Argan, Inc. (NYSE: AGX) (“Argan” or the “Company”) today announces that its Board of Directors (the “Board”) approved an increase to the Company’s existing share repurchase program from $150 million to $200 million and extended the expiration date through January 31, 2030. The Board also declared a regular quarterly cash dividend in the amount of [...]